Literature DB >> 32034064

BAFF Produced by Neutrophils and Dendritic Cells Is Regulated Differently and Has Distinct Roles in Antibody Responses and Protective Immunity against West Nile Virus.

Daniela Giordano1, Runa Kuley2, Kevin E Draves2, Kelsey Roe2, Ursula Holder2, Natalia V Giltiay3, Edward A Clark2,3.   

Abstract

B cell activating factor (BAFF) is essential for B cells to develop and respond to Ags. Dysregulation of BAFF contributes to the development of some autoimmune diseases and malignancies. Little is known about when, where, and how BAFF is produced in vivo and about which BAFF-producing cells contribute to B cell responses. To better understand BAFF functions, we created BAFF reporter (BAFF-RFP) mice and Baff floxed (Bafffl/fl ) mice. Splenic and bone marrow neutrophils (Nphs) from BAFF-RFP mice expressed the highest constitutive levels of BAFF; other myeloid subsets, including conventional dendritic cells (cDCs) and monocyte (MO) subsets, expressed lower levels. Treatment of BAFF-RFP mice with polyinosinic:polycytidylic acid increased BAFF expression in splenic Ly6Chi inflammatory MOs, CD11bhi activated NK subset, and in bone marrow myeloid precursors. Postinfection with West Nile virus (WNV), BAFF increased in CD8- cDCs and Nphs, and BAFF+ CD11bhi NK cells expanded in draining lymph nodes. The cell- and tissue-specific increases in BAFF expression were dependent on type I IFN signaling. MAVS also was required or contributed to BAFF expression in dendritic cell and MO subsets, respectively. Mice with deletion of Baff in either cDCs or Nphs had reduced Ab responses after NP-Ficoll immunization; thus, BAFF produced by both cDCs and Nphs contributes to T cell-independent Ab responses. Conversely, mice with a cDC Baff deficiency had increased mortality after WNV infection and decreased WNV-specific IgG and neutralizing Ab responses. BAFF produced by Nphs and cDCs is regulated differently and has key roles in Ab responses and protective immunity.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32034064     DOI: 10.4049/jimmunol.1901120

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells.

Authors:  Casper Marsman; Dorit Verhoeven; Jana Koers; Theo Rispens; Anja Ten Brinke; S Marieke van Ham; Taco W Kuijpers
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease.

Authors:  Xunyao Wu; Yu Peng; Jieqiong Li; Panpan Zhang; Zheng Liu; Hui Lu; Linyi Peng; Jiaxin Zhou; Yunyun Fei; Xiaofeng Zeng; Yan Zhao; Wen Zhang
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  A dominant function of LynB kinase in preventing autoimmunity.

Authors:  Ben F Brian; Monica L Sauer; Joseph T Greene; S Erandika Senevirathne; Anders J Lindstedt; Olivia L Funk; Brian L Ruis; Luis A Ramirez; Jennifer L Auger; Whitney L Swanson; Myra G Nunez; Branden S Moriarity; Clifford A Lowell; Bryce A Binstadt; Tanya S Freedman
Journal:  Sci Adv       Date:  2022-04-22       Impact factor: 14.957

Review 4.  Bite of the wolf: innate immune responses propagate autoimmunity in lupus.

Authors:  Sarthak Gupta; Mariana J Kaplan
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 5.  B cell class switching in intestinal immunity in health and disease.

Authors:  Aaron Fleming; Tomas Castro-Dopico; Menna R Clatworthy
Journal:  Scand J Immunol       Date:  2022-01-12       Impact factor: 3.889

6.  Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy.

Authors:  Mar Naranjo-Gomez; Marine Cahen; Jennifer Lambour; Myriam Boyer-Clavel; Mireia Pelegrin
Journal:  Vaccines (Basel)       Date:  2021-02-08

7.  Neutrophils recruited to immunization sites initiating vaccine-induced antibody responses by locally expressing BAFF.

Authors:  Yangyang Wang; Kuo Qu; Wenting Lu; Peiyan Zhao; Zhe Wang; Cuiyun Cui; Ye Liu; Ming Yang; Yongli Yu; Liying Wang
Journal:  iScience       Date:  2022-05-23

Review 8.  Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.

Authors:  Kyriakos A Kirou; Maria Dall Era; Cynthia Aranow; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.